Tandem Diabetes Care (TNDM) Other Gross PP&E Adjustments (2013 - 2026)

Tandem Diabetes Care has reported Other Gross PP&E Adjustments for 14 years, with the latest figure at -$95.7 million in Q1 2026.

• For the quarter ending Q1 2026, Other Gross PP&E Adjustments rose 5.22% year-over-year to -$95.7 million; the trailing twelve-month figure through Mar 2026 stood at -$95.7 million (up 5.22% YoY), and the FY2025 full-year result was $60.5 million, up 8.59% from the prior year.
• Other Gross PP&E Adjustments for Q1 2026 stood at -$95.7 million, down from $60.5 million in the prior quarter.
• The five-year high for Other Gross PP&E Adjustments was $60.5 million in Q4 2025, with the low at -$126.7 million in Q2 2022.
• Historically, Other Gross PP&E Adjustments has averaged -$66.0 million across 5 years, with a median of -$91.1 million in 2023.
• Annual changes were most pronounced in 2022 — Other Gross PP&E Adjustments tumbled 611.92% — and 2023, when it surged 194.62%.
• Tandem Diabetes Care's Other Gross PP&E Adjustments stood at $14.1 million in 2022, then surged by 194.62% to $41.5 million in 2023, then surged by 34.0% to $55.7 million in 2024, then grew by 8.59% to $60.5 million in 2025, then plunged by 258.37% to -$95.7 million in 2026.
• The last three Other Gross PP&E Adjustments figures came in at -$95.7 million (Q1 2026), $60.5 million (Q4 2025), and -$98.4 million (Q3 2025), per Business Quant data.